osimertinib,blu-945
blueprint medicines,astrazeneca,roche
['lung', 'blu-945', 'lcsm,(-blcsm)', 'osimertinib', 'blu-945 ', 'symphony', 'nsclc', 'sclc']
#asco #lungcancer #lcsm md anderson cancer center
blu-945 monotherapy and in combination with osimertinib (osi) in previously treated patients with advanced egfr-mutant (egfrm) nsclc in the phase 1/2 symphony study. abstract: 9011 
Working to improve and save lives by funding groundbreaking research for the prevention, diagnosis, treatment and cure of lung cancer.